Clinical efficacy and safety of convalescent plasma therapy for patients with SARS-CoV-2 infection

Aim: to evaluate the efficacy and safety of convalescent plasma therapy for patients with severe SARS-CoV-2 infection.Materials and methods: the study included 64 patients with laboratory-confirmed severe new coronavirus infection. The control group consisted of 58 patients who, in addition to stand...

Celý popis

Podrobná bibliografie

Hlavní autoři:	D. V. Lavrenchuk, K. V. Zhdanov, K. V. Kozlov, O. V. Mal’cev, V. V. Gordienko, K. V. Kas’janenko, A. V. Kushnir, I. A. Vorob’jov, A. M. Ivanov, V. Nю Vil’janinov, M. E. Meshkova, Yu. V. Nikitin, E. B. Masalov
Médium:	Artigo
Jazyk:	Russo
Vydáno:	Journal Infectology 2022-04-01
Edice:	Журнал инфектологии
Témata:	convalescent plasma novel coronavirus infection covid-19 sars-cov-2
On-line přístup:	https://journal.niidi.ru/jofin/article/view/1308
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!